Sanofi (SNY) Stock Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SNY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNY, but not buy additional shares or sell existing shares.
View SNY analyst ratings or view top-rated stocks.

9 Wall Street research analysts have issued twelve-month target prices for Sanofi's stock. Their SNY share price forecasts range from $60.00 to $119.00. On average, they anticipate the company's share price to reach $94.50 in the next twelve months. This suggests a possible upside of 85.3% from the stock's current price.
View analysts price targets for SNY or view top-rated stocks among Wall Street analysts.

Sanofi's stock was trading at $48.43 at the start of the year. Since then, SNY shares have increased by 5.3% and is now trading at $51.01.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our SNY earnings forecast.

Sanofi (NASDAQ:SNY) issued its quarterly earnings data on Thursday, April, 27th. The company reported $1.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.06. The firm earned $10.97 billion during the quarter, compared to analyst estimates of $11.60 billion. Sanofi had a net margin of 15.41% and a trailing twelve-month return on equity of 28.45%.

Sanofi declared an annual dividend on Tuesday, May 30th. Stockholders of record on Wednesday, May 31st will be given a dividend of $1.377 per share on Friday, June 23rd. This represents a dividend yield of 2.94%. The ex-dividend date of this dividend is Tuesday, May 30th.
Read our dividend analysis for SNY.

ETFs with the largest weight of Sanofi (NASDAQ:SNY) stock in their portfolio include Pacer BioThreat Strategy ETF (VIRS), VanEck Pharmaceutical ETF (PPH), Subversive Mental Health ETF (SANE), Simplify Health Care ETF (PINK), Horizon Kinetics Medical ETF (MEDX), Invesco International Dividend Achievers ETF (PID), Putnam Focused Large Cap Value ETF (PVAL) and Amplify International Enhanced Dividend Income ETF (IDVO).

Sanofi (NASDAQ:SNY) pays an annual dividend of $1.38 per share and currently has a dividend yield of 2.73%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 49.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SNY will have a dividend payout ratio of 28.57% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SNY.

277 employees have rated Sanofi Chief Executive Officer Paul Hudson on Glassdoor.com. Paul Hudson has an approval rating of 94% among the company's employees. This puts Paul Hudson in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include AbbVie (ABBV), Abbott Laboratories (ABT), Adobe (ADBE), Amgen (AMGN), Broadcom (AVGO), Boeing (BA), Alibaba Group (BABA), Bank of America (BAC) and BP (BP).

Sanofi trades on the NASDAQ under the ticker symbol "SNY."

Sanofi's stock is owned by a number of retail and institutional investors. Top institutional investors include Dodge & Cox (3.27%), FMR LLC (0.92%), Boston Partners (0.71%), Fisher Asset Management LLC (0.53%), Bank of America Corp DE (0.42%) and BlackRock Inc. (0.40%).
View institutional ownership trends.

Shares of SNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNY stock can currently be purchased for approximately $51.01.

Sanofi (NASDAQ:SNY) has a market capitalization of $128.64 billion and generates $45.31 billion in revenue each year. The company earns $8.82 billion in net income (profit) each year or $2.79 on an earnings per share basis.

The company employs 91,573 workers across the globe.

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The official website for the company is www.sanofi.com. The company can be reached via phone at (315) 377-4000, via email at ir@sanofi.com, or via fax at 33-1-53-77-43-03.